Filing Details
- Accession Number:
- 0001209191-18-062934
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-17 16:19:14
- Reporting Period:
- 2018-12-17
- Accepted Time:
- 2018-12-17 16:19:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1169245 | Phasebio Pharmaceuticals Inc | PHAS | Pharmaceutical Preparations (2834) | 030375697 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1379222 | J Nancy Hutson | C/O Phasebio Pharmaceuticals, Inc. 1 Great Valley Parkway, Suite 30 Malvern PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-12-17 | 1,000 | $4.46 | 1,000 | No | 4 | P | Indirect | Held in an individual retirement account for the benefit of the reporting person |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Held in an individual retirement account for the benefit of the reporting person |